Redirect to:
Latrepirdine (INN, also known as dimebolin and sold as Dimebon) is an antihistamine drug which has been used clinically in Russia since 1983. Research...
Click to read more »when attempting to ameliorate disease severity. An example is the drug Dimebon by Medivation, Inc. In 2009 this drug was in phase III clinical trials...
Click to read more »coenzyme Q10, riluzole, creatine, minocycline, ethyl-EPA, phenylbutyrate and dimebon. AB-1001 Childhood dementia Votoplam Dayalu P, Albin RL (February 2015)...
Click to read more »(Neiromidin) – acetylcholinesterase inhibitor Latrepirdine (dimebolin; Dimebon) – antihistamine, antiserotonergic, nootropic Mecigestone (pentarane B)...
Click to read more »P7C3 (pool 7, compound 3) is a drug related to latrepirdine (dimebon) which has neuroprotective and proneurogenic effects and may be potentially useful...
Click to read more »PMID 16537199. S2CID 39505659. Wu J, Li Q, Bezprozvanny I (2008). "Evaluation of Dimebon in cellular model of Huntington's disease". Molecular Neurodegeneration...
Click to read more »Paul S; Bachurin, Sergey O; Seely, Lynn; Hung, David (2008). "Effect of dimebon on cognition, activities of daily living, behaviour, and global function...
Click to read more »PMID 35835867. Wu J, Li Q, Bezprozvanny I (October 2008). "Evaluation of Dimebon in cellular model of Huntington's disease". Molecular Neurodegeneration...
Click to read more »Cyproheptadine Desipramine Desloratadine Dicycloverine Dicyclomine Dilazep Dimebon Doxepin Drofenine Emetine Fendiline Flunarizine Fluoxetine Flupentixol...
Click to read more »Medivation made false and misleading statements regarding the effectiveness of Dimebon as a treatment for Alzheimer's disease, before being revealed that it did...
Click to read more »